1. Home
  2. CXT vs SUPN Comparison

CXT vs SUPN Comparison

Compare CXT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane NXT Co.

CXT

Crane NXT Co.

HOLD

Current Price

$41.88

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$48.93

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXT
SUPN
Founded
1855
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
1994
2010

Fundamental Metrics

Financial Performance
Metric
CXT
SUPN
Price
$41.88
$48.93
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$76.75
$61.60
AVG Volume (30 Days)
688.2K
693.7K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
N/A
EPS
2.50
N/A
Revenue
$3,374,900,000.00
$392,755,000.00
Revenue This Year
$5.75
$23.19
Revenue Next Year
$4.22
$17.65
P/E Ratio
$16.57
N/A
Revenue Growth
6.13
N/A
52 Week Low
$41.43
$29.16
52 Week High
$69.00
$59.68

Technical Indicators

Market Signals
Indicator
CXT
SUPN
Relative Strength Index (RSI) 23.09 37.79
Support Level N/A $47.95
Resistance Level $61.93 $52.14
Average True Range (ATR) 1.50 2.04
MACD -0.51 -0.69
Stochastic Oscillator 11.98 12.41

Price Performance

Historical Comparison
CXT
SUPN

About CXT Crane NXT Co.

Crane NXT Co is a industrial technology company that provides proprietary and trusted technology solutions to secure, detect, and authenticate what matters to its customers. It is a pioneer in proprietary micro-optics technology for securing physical products, and its sophisticated electronic equipment and associated software leverages proprietary core capabilities with detection and sensing technologies. The company operates in two segments which are Crane Payment Innovations (CPI) and Security and Authentication Technologies.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: